TABLE 4.
Mutation(s) in RT | Phenotypic susceptibility data: EC50 fold change (SD)a |
|||
---|---|---|---|---|
DLV | EFV | NVP | ZDV | |
T369I | 5.2 (0.50) | 2.4 (0.40) | 8.4 (0.50) | 2.7 (0.80) |
T369Vb | 5.5 | 3.1 | 9.2 | 2.1 |
N348I | 3.4 (0.30) | 1.9 (0.30) | 4.1 (0.10) | 2.4 (0.90) |
T369I/N348I | 29.8 (1.70) | 8.1 (3.10) | 58.6 (2.20) | 5.4 (1.20) |
K103N | 75.7 (16.80) | 21.3 (9.50) | 81 (41.4) | 1.1 (0.30) |
K103N/N348I | >250 (NAc) | 115 (41.2) | >400 (NA) | 2.6 (1) |
K103N/T369I | >250 (NA) | 164.1 (77.40) | >400 (NA) | 2.3 (0.70) |
K103N/T369I/N348I | >250 (NA) | >700 (NA) | >400 (NA) | 7.9 (0) |
Y181C | 44.7 (6.70) | 1.7 (0.10) | 317 (143.8) | 0.3 (0.10) |
Y181C/N348I | >250 (NA) | 3.2 (0.20) | >400 (NA) | 0.7 (0.10) |
Y181C/T369I | >250 (NA) | 4 (0.8) | >400 (NA) | 0.9 (0.30) |
Y181C/T369I/N348I | >250 (NA) | 17 (6.2) | >400 (NA) | 2.2 (0.60) |
G190A | 0.3 (0.10) | 5.2 (1.50) | 127.7 (30.10) | 1.1 (0.20) |
G190A/N348Ib | 1.1 | 26.0 | >400 | 2.0 |
G190A/T369I | 1.2 (0.10) | 33.7 (9) | >400 (NA) | 1.7 (0.20) |
G190A/T369I/N348I | 5.9 (0.80) | >700 (NA) | >400 (NA) | 4.2 (2.10) |
G190S | 0.3 (0.04) | 63 (9.9) | 145 (65.1) | 0.8 (0.02) |
G190S/N348I | 0.9 (0.20) | >700 (NA) | >400 (NA) | 1.7 (0.40) |
G190S/T369I | 0.6 (0.10) | >700 (NA) | >400 (NA) | 0.7 (0.20) |
G190S/T369I/N348I | 6.9 (0.30) | >700 (NA) | >400 (NA) | 5.8 (0.30) |
L100I | 34 (0) | 9 (0.1) | 2.1 (0) | 0.1 (0) |
L100I/N348I | 90.7 (7.20) | 16 (4.4) | 5.3 (0.60) | 0.3 (0.20) |
L100I/T369I | 49.7 (9.60) | 13.6 (4.80) | 4.8 (0.50) | 0.2 (0.10) |
L100I/T369I/N348I | >250 (NA) | 137.7 (50.50) | 56.3 (4.20) | 0.5 (0.20) |
The data represent mean fold changes (± standard deviations) obtained from the results of three independent experiments. Changes in phenotypic susceptibility are expressed as the fold change in EC50 based on the EC50 of a drug-susceptible reference virus (EC50 of sample/EC50 of reference).
Results are from single experiments testing for these two viruses.
NA, standard deviations could not be calculated, as the EC50s were greater than the highest drug concentrations tested.